Read our previous insight-driven newsletters covering business, finance, economics and tech.
Plus: Moderna finally gets FDA approval for a non-Covid mRNA vaccine.
Plus: What expiring Medicare Part D subsidies mean for clients.
Ken Griffin’s Citadel makes a quick mint from a distressed hedge fund rival.
Plus: RIAs lose up to 5% in total AUM per year from client withdrawals.
Plus: Leveraged funds are everywhere. Should access be limited?
Caterpillar has another butterfly of a quarter.
Plus: SpaceX steps up to the plate.
Plus: Advisors expected to nearly double private allocations in next five years.